1. Introduction {#s0005}
===============

An 18 year-old woman, without medical history, requested a contraceptive implant. The insertion of a Nexplanon device in the left upper limb was immediately followed by an important local hematoma.

Five months later, as the patient was complaining about local pain, a removal was proposed. The implant could not be located neither clinically nor following ultrasonography. Hormone assays were positive, confirming that the implant was present in the patient\'s body.

Complementary radiography, CT and MRI were performed but failed in locating the implant, despite a scanning covering all left upper limb.

At last, a chest radiograph was performed looking for a possible migration. It showed a linear opaque structure in the pulmonary hemi-right field, whose size and shape were compatible with the Nexplanon ([Figs. 1-2](#f0005){ref-type="fig"}). A contrast-enhanced thoracic CT scan confirmed the migration and specified its location in the upper right lobar artery, extending into the apical segmental artery, with associated arterial stenosis ([Fig. 3](#f0010){ref-type="fig"}). Retrieval of the embolized device was decided.Figs. 1-2CXR showing a linear opaque structure in pulmonary hemi-right field.Fig. 3Coronal thoracic CT scan with injection showing the Nexplanon in the upper right lobar artery.

The implant was removed by percutaneous interventional technique through a right femoral vein access. The device was captured with a loop snare after mobilization without complication ([Fig. 4](#f0015){ref-type="fig"}, [Fig. 5](#f0020){ref-type="fig"}).Fig. 4Interventional technique: capture with a loop snare.Fig. 5Nexplanon after removal.

2. Discussion {#s0010}
=============

The Nexplanon is a long-active progestogen-only contraceptive method that contains 68 mg etonogestrel. It is a very efficient contraceptive method (Pearl Index 0) [@bb0005], with irregular periods as main side effect. The subcutaneous implant is radiopaque, contrary to the Implanon device.

Significant migrations (\> 2 cm) are uncommon, and primarily occur caudally looking to the insertion site [@bb0010]. Other previously described side effects at the time of the removal are deep insertion, fibrous adhesions and broken implant. Their prevalence is about 1% [@bb0015].

In our case, we think that an inadvertent placement of the Nexplanon into the basilic vein occurred during the initial procedure, explaining the important hematoma after insertion. The Nexplanon probably got through the upper limb veins, the right heart chambers before stopping in the pulmonary artery ([Fig. 6](#f0025){ref-type="fig"}).Fig. 6Ride of the Nexplanon.

Instructions for insertion state that Nexplanon should be placed subdermally at the inner side of the upper nondominant arm about 7 cm above the elbow crease in the groove between the biceps and the triceps. It is stated that correct placement of the implant in the arm limits implant migration [@bb0030]. By tenting the skin, the operator should avoid a deep insertion and complications like endovascular insertion.

In cases of troubles to locate a non-palpable implant before removal, ultrasound guidance is recommended by first intention with a nearly 100% efficiency [@bb0020]. It appears as a hyperechoic line with a posterior shadow cone. Hormonal assay also confirms or denies the presence of the device. In case of a positive assay, the strategy was previously based on MRI. Today, the use of Nexplanon, which is radiopaque, allows the use of plain radiographies.

When radiography or CT scan of the upper limb fail, a more distant migration has to be considered and chest radiograph should be performed.

To our knowledge, only one case of distant pulmonary artery migration far from the insertion site has been reported, also diagnosed by chest radiograph after an episode of chest pain [@bb0025]. In this case, no information was reported about difficulties with insertion of the implant. The device was lodged in a subsegmental branch of the left lower lobe pulmonary artery. Options of retrieval were discussed, but the patient opted against intervention. Endovascular removal of a contraceptive implant in pulmonary artery has not been reported before our case.

Cardiopulmonary complications after a contraceptive implant migration in pulmonary artery may be serious including infection and thrombosis. Exact location is crucial as endovascular procedures are now considered as the best way to retrieve endovascular foreign bodies with high success rate and low morbidity.
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